Seleção de novas moléculas e modalidades de tratamento no combate ao câncer

Detalhes bibliográficos
Ano de defesa: 2012
Autor(a) principal: Nedel, Fernanda
Orientador(a): Seixas, Fabiana Kömmling
Banca de defesa: Não Informado pela instituição
Tipo de documento: Tese
Tipo de acesso: Acesso aberto
Idioma: por
Instituição de defesa: Universidade Federal de Pelotas
Programa de Pós-Graduação: Programa de Pós-Graduação em Biotecnologia
Departamento: Biotecnologia
País: BR
Palavras-chave em Português:
Palavras-chave em Inglês:
Área do conhecimento CNPq:
Link de acesso: http://repositorio.ufpel.edu.br/handle/ri/1209
Resumo: Cancer is a leading cause of death and its rates are expected to increase 50% by 2020. Although surgical resection and additional therapies (such as chemotherapy and radiotherapy) are able to cure well-confined, primary tumors, the same does not apply during metastasis due to the systemic involvement and its resistance to conventional therapies. Therefore, the current clinical challenge is to develop new drugs and treatment modalities that will significantly impact the cure rates. In this sense, the present study aimed to evaluate the anticancer effect and study the underlying cell death mechanisms of diaryl diselenides and its substituted structures - (4-ClC6H4Se)2, (3-CF3C6H4Se)2 e (4-MeOC6H4Se)2 - on the human colon adenocarcinoma cell line (HT-29). We verified that (3-CF3C6H4Se)2 and (4-MeOC6H4Se)2 induced cytotoxicity through apoptosis mechanisms in HT-29 cells, where pro-apoptotic genes were up-regulated (Bax, caspase-9, caspase-8, apoptosis-inducing factor (AIF) and endonuclease G (EndoG), and anti-apoptotic genes were down-regulated (Bcl-2 and survivin). In a second moment we evaluated the anticancer potential of Canavalia brasiliensis (ConBr), Canavalia boliviana (ConBol) and Canavalia ensiformis (ConA) lectins in HT-29 cells, which showed an effective capacity to reduce cell viability. Once the anticancer effect was confirmed, lectins were labeled with FITC and its interaction with the tumor cells was investigated. The FITC-ConA and FITC-ConBol demonstrated the potential to bind to HT-29 cells unlike FITC-ConBr. In order to investigate a new treatment modality, the interaction between the respective lectins with HT-29 was evaluated when associated with functionalized multi-walled carbon nanotubes (f-MWCNTs). When f-MWNT was incorporated to FITC-ConBol and FITC-ConA lectins there was an increase in fluorescence intensity.
id UFPL_9f365f861cb902b921267bdeeec5e538
oai_identifier_str oai:guaiaca.ufpel.edu.br:123456789/1209
network_acronym_str UFPL
network_name_str Repositório Institucional da UFPel - Guaiaca
repository_id_str
spelling 2014-08-20T13:32:46Z2013-10-312014-08-20T13:32:46Z2012-09-17NEDEL, Fernanda. Selection of new molecules and treatment modalities to fight cancer. 2012. 89 f. Tese (Doutorado em Biotecnologia) - Universidade Federal de Pelotas, Pelotas, 2012.http://repositorio.ufpel.edu.br/handle/ri/1209Cancer is a leading cause of death and its rates are expected to increase 50% by 2020. Although surgical resection and additional therapies (such as chemotherapy and radiotherapy) are able to cure well-confined, primary tumors, the same does not apply during metastasis due to the systemic involvement and its resistance to conventional therapies. Therefore, the current clinical challenge is to develop new drugs and treatment modalities that will significantly impact the cure rates. In this sense, the present study aimed to evaluate the anticancer effect and study the underlying cell death mechanisms of diaryl diselenides and its substituted structures - (4-ClC6H4Se)2, (3-CF3C6H4Se)2 e (4-MeOC6H4Se)2 - on the human colon adenocarcinoma cell line (HT-29). We verified that (3-CF3C6H4Se)2 and (4-MeOC6H4Se)2 induced cytotoxicity through apoptosis mechanisms in HT-29 cells, where pro-apoptotic genes were up-regulated (Bax, caspase-9, caspase-8, apoptosis-inducing factor (AIF) and endonuclease G (EndoG), and anti-apoptotic genes were down-regulated (Bcl-2 and survivin). In a second moment we evaluated the anticancer potential of Canavalia brasiliensis (ConBr), Canavalia boliviana (ConBol) and Canavalia ensiformis (ConA) lectins in HT-29 cells, which showed an effective capacity to reduce cell viability. Once the anticancer effect was confirmed, lectins were labeled with FITC and its interaction with the tumor cells was investigated. The FITC-ConA and FITC-ConBol demonstrated the potential to bind to HT-29 cells unlike FITC-ConBr. In order to investigate a new treatment modality, the interaction between the respective lectins with HT-29 was evaluated when associated with functionalized multi-walled carbon nanotubes (f-MWCNTs). When f-MWNT was incorporated to FITC-ConBol and FITC-ConA lectins there was an increase in fluorescence intensity.O câncer é uma das principais causas de morte no mundo, onde os índices devem aumentar 50% até 2020. Embora a ressecção cirúrgica e terapias adicionais (como a quimioterapias e radioterapias) sejam capazes de curar tumores primários bem delimitados, o mesmo não se aplica a metástase devido ao seu envolvimento sistêmico e a resistência a terapias convencionais. Portanto, atualmente o desfio clínico é desenvolver novas drogas e modalidades de tratamentos que irão impactar significativamente as taxas de cura do câncer. Neste sentido, o presente trabalho objetivou avaliar o efeito antineoplásico e investigar a rota de apoptose induzido pelo disseleneto de diarila e seus derivados substituídos - (4-ClC6H4Se)2, (3-CF3C6H4Se)2 e (4-MeOC6H4Se)2 - em células de adenocarcinoma de colorretal humano (HT-29). Verificamos que os compostos (3-CF3C6H4Se)2 e (4-MeOC6H4Se)2 induziram um efeito citotoxidade por meio de apoptose, onde os genes pró-apoptoticos (Bax, caspase-9, caspase-8, fator indutor de apoptose (AIF) e endonuclease G (EndoG)) foram altamente expressos e os genes anti-apoptótico (Bcl-2 e survivin) mostraram uma redução na sua expressão. Em um segundo momento avaliamos o potencial antineoplásico das lectinas Canavalia brasiliensis (ConBr), Canavalia boliviana (ConBol) e Canavalia ensiformis (ConA) em células HT-29, as quais se mostraram efetivas em reduzir a viabilidade celular. Uma vez confirmado o efeito antineoplásico, as lectinas forma marcadas com FITC e a sua interação com as células tumorais foi investigado. As lectinas FITC-ConA e FITC-ConBol demonstraram potencial de se ligar as células HT-29 ao contrário da FITC-ConBr. A fim de investigar uma nova modalidade de tratamento foi avaliada a interação entre as respectivas lectinas com as células HT-29 quando associadas à nanotubos de carbonos funcionalizados de paredes múltiplas (f-MWCNTs). Quando os f-MWCNTs foram incorporados as lectinas FITC-ConA e FITC-ConBol houve um aumentaram na intensidade de fluorescência.application/pdfporUniversidade Federal de PelotasPrograma de Pós-Graduação em BiotecnologiaUFPelBRBiotecnologiaBiotecnologiaAdenocarcinoma de colorretal humanoDisseleneto de diarila e seus derivados substituídosLectinasNanotubos de carbonoBiotechnologyHuman colon adenocarcinomaSubstituted diaryl diselenidesLectinsCarbon nanotubesCNPQ::CIENCIAS BIOLOGICAS::BIOQUIMICASeleção de novas moléculas e modalidades de tratamento no combate ao câncerSelection of new molecules and treatment modalities to fight cancerinfo:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/doctoralThesishttp://lattes.cnpq.br/9529308180586356http://buscatextual.cnpq.br/buscatextual/visualizacv.do?id=K4779073P1Collares, Tiago VeirasTarquino, Sandra Beatriz ChavesSandra Beatriz Chaves TarquinoSeixas, Fabiana KömmlingNedel, Fernandainfo:eu-repo/semantics/openAccessreponame:Repositório Institucional da UFPel - Guaiacainstname:Universidade Federal de Pelotas (UFPEL)instacron:UFPELORIGINALtese_fernanda_nedel.pdfapplication/pdf5232153http://guaiaca.ufpel.edu.br/xmlui/bitstream/123456789/1209/1/tese_fernanda_nedel.pdf94c9f4584571a1e142e44a8b165fc8ddMD51open accessTEXTtese_fernanda_nedel.pdf.txttese_fernanda_nedel.pdf.txtExtracted Texttext/plain114322http://guaiaca.ufpel.edu.br/xmlui/bitstream/123456789/1209/2/tese_fernanda_nedel.pdf.txtc88328229331e4b4611717cf407f72bcMD52open accessTHUMBNAILtese_fernanda_nedel.pdf.jpgtese_fernanda_nedel.pdf.jpgGenerated Thumbnailimage/jpeg1770http://guaiaca.ufpel.edu.br/xmlui/bitstream/123456789/1209/3/tese_fernanda_nedel.pdf.jpg929f9fddde5106cb3d95e96f02ebff46MD53open access123456789/12092019-08-23 10:44:30.736open accessoai:guaiaca.ufpel.edu.br:123456789/1209Repositório InstitucionalPUBhttp://repositorio.ufpel.edu.br/oai/requestrippel@ufpel.edu.br || repositorio@ufpel.edu.br || aline.batista@ufpel.edu.bropendoar:2019-08-23T13:44:30Repositório Institucional da UFPel - Guaiaca - Universidade Federal de Pelotas (UFPEL)false
dc.title.por.fl_str_mv Seleção de novas moléculas e modalidades de tratamento no combate ao câncer
dc.title.alternative.eng.fl_str_mv Selection of new molecules and treatment modalities to fight cancer
title Seleção de novas moléculas e modalidades de tratamento no combate ao câncer
spellingShingle Seleção de novas moléculas e modalidades de tratamento no combate ao câncer
Nedel, Fernanda
Biotecnologia
Adenocarcinoma de colorretal humano
Disseleneto de diarila e seus derivados substituídos
Lectinas
Nanotubos de carbono
Biotechnology
Human colon adenocarcinoma
Substituted diaryl diselenides
Lectins
Carbon nanotubes
CNPQ::CIENCIAS BIOLOGICAS::BIOQUIMICA
title_short Seleção de novas moléculas e modalidades de tratamento no combate ao câncer
title_full Seleção de novas moléculas e modalidades de tratamento no combate ao câncer
title_fullStr Seleção de novas moléculas e modalidades de tratamento no combate ao câncer
title_full_unstemmed Seleção de novas moléculas e modalidades de tratamento no combate ao câncer
title_sort Seleção de novas moléculas e modalidades de tratamento no combate ao câncer
author Nedel, Fernanda
author_facet Nedel, Fernanda
author_role author
dc.contributor.authorLattes.por.fl_str_mv http://lattes.cnpq.br/9529308180586356
dc.contributor.advisorLattes.por.fl_str_mv http://buscatextual.cnpq.br/buscatextual/visualizacv.do?id=K4779073P1
dc.contributor.referees1.pt_BR.fl_str_mv Tarquino, Sandra Beatriz Chaves
dc.contributor.referees1ID.por.fl_str_mv
dc.contributor.referees1Lattes.por.fl_str_mv Sandra Beatriz Chaves Tarquino
dc.contributor.advisor-co1.fl_str_mv Collares, Tiago Veiras
dc.contributor.advisor1.fl_str_mv Seixas, Fabiana Kömmling
dc.contributor.author.fl_str_mv Nedel, Fernanda
contributor_str_mv Collares, Tiago Veiras
Seixas, Fabiana Kömmling
dc.subject.por.fl_str_mv Biotecnologia
Adenocarcinoma de colorretal humano
Disseleneto de diarila e seus derivados substituídos
Lectinas
Nanotubos de carbono
topic Biotecnologia
Adenocarcinoma de colorretal humano
Disseleneto de diarila e seus derivados substituídos
Lectinas
Nanotubos de carbono
Biotechnology
Human colon adenocarcinoma
Substituted diaryl diselenides
Lectins
Carbon nanotubes
CNPQ::CIENCIAS BIOLOGICAS::BIOQUIMICA
dc.subject.eng.fl_str_mv Biotechnology
Human colon adenocarcinoma
Substituted diaryl diselenides
Lectins
Carbon nanotubes
dc.subject.cnpq.fl_str_mv CNPQ::CIENCIAS BIOLOGICAS::BIOQUIMICA
description Cancer is a leading cause of death and its rates are expected to increase 50% by 2020. Although surgical resection and additional therapies (such as chemotherapy and radiotherapy) are able to cure well-confined, primary tumors, the same does not apply during metastasis due to the systemic involvement and its resistance to conventional therapies. Therefore, the current clinical challenge is to develop new drugs and treatment modalities that will significantly impact the cure rates. In this sense, the present study aimed to evaluate the anticancer effect and study the underlying cell death mechanisms of diaryl diselenides and its substituted structures - (4-ClC6H4Se)2, (3-CF3C6H4Se)2 e (4-MeOC6H4Se)2 - on the human colon adenocarcinoma cell line (HT-29). We verified that (3-CF3C6H4Se)2 and (4-MeOC6H4Se)2 induced cytotoxicity through apoptosis mechanisms in HT-29 cells, where pro-apoptotic genes were up-regulated (Bax, caspase-9, caspase-8, apoptosis-inducing factor (AIF) and endonuclease G (EndoG), and anti-apoptotic genes were down-regulated (Bcl-2 and survivin). In a second moment we evaluated the anticancer potential of Canavalia brasiliensis (ConBr), Canavalia boliviana (ConBol) and Canavalia ensiformis (ConA) lectins in HT-29 cells, which showed an effective capacity to reduce cell viability. Once the anticancer effect was confirmed, lectins were labeled with FITC and its interaction with the tumor cells was investigated. The FITC-ConA and FITC-ConBol demonstrated the potential to bind to HT-29 cells unlike FITC-ConBr. In order to investigate a new treatment modality, the interaction between the respective lectins with HT-29 was evaluated when associated with functionalized multi-walled carbon nanotubes (f-MWCNTs). When f-MWNT was incorporated to FITC-ConBol and FITC-ConA lectins there was an increase in fluorescence intensity.
publishDate 2012
dc.date.issued.fl_str_mv 2012-09-17
dc.date.available.fl_str_mv 2013-10-31
2014-08-20T13:32:46Z
dc.date.accessioned.fl_str_mv 2014-08-20T13:32:46Z
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
dc.type.driver.fl_str_mv info:eu-repo/semantics/doctoralThesis
format doctoralThesis
status_str publishedVersion
dc.identifier.citation.fl_str_mv NEDEL, Fernanda. Selection of new molecules and treatment modalities to fight cancer. 2012. 89 f. Tese (Doutorado em Biotecnologia) - Universidade Federal de Pelotas, Pelotas, 2012.
dc.identifier.uri.fl_str_mv http://repositorio.ufpel.edu.br/handle/ri/1209
identifier_str_mv NEDEL, Fernanda. Selection of new molecules and treatment modalities to fight cancer. 2012. 89 f. Tese (Doutorado em Biotecnologia) - Universidade Federal de Pelotas, Pelotas, 2012.
url http://repositorio.ufpel.edu.br/handle/ri/1209
dc.language.iso.fl_str_mv por
language por
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
dc.publisher.none.fl_str_mv Universidade Federal de Pelotas
dc.publisher.program.fl_str_mv Programa de Pós-Graduação em Biotecnologia
dc.publisher.initials.fl_str_mv UFPel
dc.publisher.country.fl_str_mv BR
dc.publisher.department.fl_str_mv Biotecnologia
publisher.none.fl_str_mv Universidade Federal de Pelotas
dc.source.none.fl_str_mv reponame:Repositório Institucional da UFPel - Guaiaca
instname:Universidade Federal de Pelotas (UFPEL)
instacron:UFPEL
instname_str Universidade Federal de Pelotas (UFPEL)
instacron_str UFPEL
institution UFPEL
reponame_str Repositório Institucional da UFPel - Guaiaca
collection Repositório Institucional da UFPel - Guaiaca
bitstream.url.fl_str_mv http://guaiaca.ufpel.edu.br/xmlui/bitstream/123456789/1209/1/tese_fernanda_nedel.pdf
http://guaiaca.ufpel.edu.br/xmlui/bitstream/123456789/1209/2/tese_fernanda_nedel.pdf.txt
http://guaiaca.ufpel.edu.br/xmlui/bitstream/123456789/1209/3/tese_fernanda_nedel.pdf.jpg
bitstream.checksum.fl_str_mv 94c9f4584571a1e142e44a8b165fc8dd
c88328229331e4b4611717cf407f72bc
929f9fddde5106cb3d95e96f02ebff46
bitstream.checksumAlgorithm.fl_str_mv MD5
MD5
MD5
repository.name.fl_str_mv Repositório Institucional da UFPel - Guaiaca - Universidade Federal de Pelotas (UFPEL)
repository.mail.fl_str_mv rippel@ufpel.edu.br || repositorio@ufpel.edu.br || aline.batista@ufpel.edu.br
_version_ 1797769978954383360